%20(1).png)
Unlocking Healthcare
Investment Potential
WHO WE ARE
Caliburn Capital is a newly formed healthcare-focused investment holding company targeting
above-market returns through special situation and majority recapitalization investments in companies with attractive market dynamics, unique growth opportunities and leverageable assets.
WHAT WE DO
Caliburn Capital is the flagship for an innovative investment program, meticulously engineered by a registered insurance firm. This groundbreaking program allows fixed income investors and investment capital compliant companies access to project financing opportunities historically exclusive to private equity.
WHERE WE DO IT
We are focused on
healthcare-related markets, products, services and companies that represent opportunities to grow and develop into market leadership positions through access to operating and capital investment, geographic expansion, and exceptional leadership team support.
Maximizing Value with a
Hands-On Approach
Caliburn Capital applies a unique, two-pronged evaluation and investment approach that identifies companies with solid fundamentals to acquire, grow, and exit in their own right with incremental opportunities for value creation by leveraging assets and competitive advantages across portfolio companies.
Opportunity Identification & Screening
Diligence & Feasibility
Deal
Execution
Strategic & Operational Optimization
Exit Strategy Optimization
Exit
Planning
Exit
Execution
A Leadership Team with a Proven Track Record
Our management team boasts a uniquely diverse range of backgrounds, curated to encompass extensive experience in investment management and banking, strategy consulting, operations, P&L management, and growth. Additionally, we possess specialized technical expertise in healthcare, operations, technology, human capital management, and value creation.
​
With approximately 20 c-suite positions and 30 board seats held both in the US and internationally, our team brings a wealth of leadership and governance acumen. Moreover, our collective track record spans decades of conducting transactions, with an impressive deal value surpassing $70 billion.
